1. Stocks
  2. Quince Therapeutics Inc
  3. Swot
swot-logo

Quince Therapeutics Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Quince Therapeutics Inc has 14 Strengths, 6 Weaknesses, 5 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Price crossing above SMA20 today, and greater than SMA5

Significant (over 30%) distance from 52 week high

Relative Outperformance versus Industry over 1 Month

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Good Aggregate Candlestick Strength (total bullish - bearish candlesticks)

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Month

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Company with Low Debt

Top Gainers

Stock with Low PE (PE < = 10)

Highest Recovery from 52 Week Low

Stocks with Quarter Change % less than Industry

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Low Piotroski Score : Companies with weak financials

Declining Net Cash Flow : Companies not able to generate net cash

Book Value Per Share deteriorating for last 2 years

Stocks Underperforming their Industry Price Change in the Quarter

Forecaster Consensus Estimates: Stocks with Strong Buy Calls from Analysts

Mutual Funds Increased Shareholding in Past Month

Mutual Funds Increased Shareholding over the Past Two Months

MFs increased their shareholding last quarter

Mf buying for 2 months

Institutions decreased their shareholding last quarter

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks